INSIGHTS
Read by topic: Australian TGA, Canadian MDL/MDEL, documentation and ongoing compliance.
When comparing TGA providers, establish product experience, deliverables, the Sponsor entity and ongoing maintenance before comparing like-for-like prices. This article is for medical device and IVD businesses preparing to enter Australia.
Read the full articleRegistration consulting is a commissioned service; the Sponsor bears relevant Australian supply and regulatory responsibilities. Confirm tasks, responsible entity and continuing cooperation separately when selecting partners.
Read the full articleA TGA project budget should distinguish provider fees, official application and assessment fees, ongoing annual costs and possible third-party work. Confirm the product and deliverables before comparing quotes.
Read the full articleStart with product use, classification and Sponsor arrangements to clarify documentation, application and post-market responsibilities.
Read the full articleMedical device classification depends on intended use and applicable rules. Describe the use setting before assessing documentation and pathways.
Read the full articleSeparate documentation preparation from regulatory processing and plan registration around evidence completeness, pathway and review requirements.
Read the full articleAssess whether Sponsor arrangements suit your Australian plans by reviewing document cooperation, ongoing responsibilities and commercial handover.
Read the full articleOverseas evidence may support an Australian application if evidence type, product coverage and pathway match. Explain document names and actual status before assessing gaps. CE or FDA references alone do not determine Australian access.
Read the full articleFor the first consultation, provide the product and use, proposed Australian range, existing evidence, Australian status and current objective. Full technical files are not needed immediately, but each summary should allow both parties to identify what needs checking next.
Read the full articleFirst check UDI scope, then the relevant dates, labels and data preparation. The first requirements in July 2026 cover Class IIb and III. Existing ARTG inclusion or overseas identifiers alone do not prove Australian UDI work is complete.
Read the full articleARTG inclusion and UDI labelling, identification and data requirements address different matters. Products already included in the ARTG still need their UDI scope and batch conditions checked. A label change made solely to comply with UDI does not automatically require the entire product to be registered again.
Read the full articleDo not assume identifiers must be recreated. Qualifying EU or US UDI carriers may be accepted in Australia, but issuing agencies, labels, product scope and Australian data arrangements still need separate checks. Reusable identifiers do not remove the need for Australian project preparation.
Read the full articleWhen changing intended use, models, manufacturer details or supporting evidence, include Australian implications in the assessment. Handle safety signals and complaints promptly under applicable procedures. Do not wait until the next shipment to inform the Sponsor.
Read the full articleReview regulatory authorization, payment pathways and commercial procurement separately, keeping each stage aligned with the same product objective.
Read the full articleDevice licensing, establishment licensing and distribution partnerships address different tasks. Clarify roles before arranging registration and market entry.
Read the full articleProvide intended use, existing authorizations and launch plans so we can assess preparation and support needs.
